GIA
REGN icon

Gateway Investment Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History

Gateway Investment Advisers’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Sell
375
-404
-52% -$275K ﹤0.01% 749
2026
Q1 		$602K Buy
779
+315
+68% +$241K 0.01% 443
2025
Q4 		$358K Buy
464
+19
+4% +$12.9K ﹤0.01% 494
2025
Q3 		$250K Sell
445
-167
-27% -$94.4K ﹤0.01% 499
2025
Q2 		$321K Sell
612
-313
-34% -$175K ﹤0.01% 414
2025
Q1 		$587K Buy
925
+113
+14% +$77.7K 0.01% 387
2024
Q4 		$578K Sell
812
-301
-27% -$253K 0.01% 375
2024
Q3 		$1.17M Buy
1,113
+166
+18% +$185K 0.01% 308
2024
Q2 		$995K Sell
947
-390
-29% -$378K 0.01% 323
2024
Q1 		$1.29M Buy
1,337
+161
+14% +$153K 0.01% 306
2023
Q4 		$1.03M Buy
1,176
+299
+34% +$246K 0.01% 319
2023
Q3 		$722K Sell
877
-38
-4% -$29.9K 0.01% 346
2023
Q2 		$657K Sell
915
-58
-6% -$44.7K 0.01% 355
2023
Q1 		$799K Sell
973
-28
-3% -$21.1K 0.01% 349
2022
Q4 		$722K Buy
1,001
+91
+10% +$67.1K 0.01% 382
2022
Q3 		$627K Sell
910
-62
-6% -$39K 0.01% 390
2022
Q2 		$575K Buy
972
+21
+2% +$13.7K 0.01% 407
2022
Q1 		$664K Sell
951
-153
-14% -$96.8K 0.01% 403
2021
Q4 		$697K Sell
1,104
-24
-2% -$14.8K 0.01% 374
2021
Q3 		$683K Sell
1,128
-25
-2% -$15.5K 0.01% 387
2021
Q2 		$644K Sell
1,153
-54
-4% -$27.4K 0.01% 397
2021
Q1 		$571K Buy
1,207
+40
+3% +$19.5K 0.01% 403
2020
Q4 		$564K Sell
1,167
-33
-3% -$17.8K 0.01% 396
2020
Q3 		$672K Sell
1,200
-92
-7% -$55.8K 0.01% 371
2020
Q2 		$806K Buy
1,292
+8
+0.6% +$4.54K 0.01% 383
2020
Q1 		$627K Buy
1,284
+278
+28% +$115K 0.01% 390
2019
Q4 		$378K Sell
1,006
-225
-18% -$75.7K ﹤0.01% 463
2019
Q3 		$341K Sell
1,231
-2,111
-63% -$625K ﹤0.01% 492
2019
Q2 		$1.05M Sell
3,342
-229
-6% -$76.2K 0.01% 445
2019
Q1 		$1.47M Buy
3,571
+226
+7% +$93.1K 0.01% 392
2018
Q4 		$1.25M Buy
3,345
+23
+0.7% +$8.42K 0.01% 421
2018
Q3 		$1.34M Sell
3,322
-48
-1% -$18.3K 0.01% 422
2018
Q2 		$1.16M Sell
3,370
-1,149
-25% -$359K 0.01% 435
2018
Q1 		$1.56M Sell
4,519
-338
-7% -$118K 0.01% 413
2017
Q4 		$1.83M Sell
4,857
-339
-7% -$137K 0.02% 410
2017
Q3 		$2.32M Sell
5,196
-111
-2% -$52.8K 0.02% 381
2017
Q2 		$2.61M Sell
5,307
-210
-4% -$91.9K 0.02% 351
2017
Q1 		$2.14M Sell
5,517
-1,054
-16% -$391K 0.02% 361
2016
Q4 		$2.41M Buy
6,571
+296
+5% +$113K 0.02% 352
2016
Q3 		$2.52M Sell
6,275
-38
-0.6% -$15.2K 0.02% 348
2016
Q2 		$2.21M Sell
6,313
-23
-0.4% -$8.86K 0.02% 361
2016
Q1 		$2.28M Sell
6,336
-2,576
-29% -$1.06M 0.02% 343
2015
Q4 		$4.84M Buy
8,912
+83
+0.9% +$45K 0.04% 281
2015
Q3 		$4.11M Sell
8,829
-227
-3% -$122K 0.04% 295
2015
Q2 		$4.62M Sell
9,056
-181
-2% -$88.3K 0.04% 290
2015
Q1 		$4.17M Sell
9,237
-16
-0.2% -$6.78K 0.03% 297
2014
Q4 		$3.8M Sell
9,253
-41,853
-82% -$16.5M 0.03% 306
2014
Q3 		$18.4M Buy
51,106
+1,790
+4% +$600K 0.15% 161
2014
Q2 		$13.9M Buy
49,316
+1,375
+3% +$408K 0.11% 195
2014
Q1 		$14.4M Sell
47,941
-25
-0.1% -$7.7K 0.12% 184
2013
Q4 		$13.2M Buy
47,966
+39,400
+460% +$11.3M 0.11% 199
2013
Q3 		$2.68M Buy
8,566
+1,270
+17% +$334K 0.02% 347
2013
Q2 		$1.64M Buy
+7,296
New +$1.7M 0.01% 406

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Gateway Investment Advisers's REGN Position: Q2 2026 in Review

Gateway Investment Advisers reduced its Regeneron Pharmaceuticals (REGN) stake by 52% in Q2 2026, selling an estimated $275K and leaving 375 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #749.

Gateway Investment Advisers first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.4M in Q3 2014. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Gateway Investment Advisers held 375 shares of Regeneron Pharmaceuticals worth $234K as of Q2 2026.
  • Gateway Investment Advisers sold 404 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $275K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #749 holding.
  • Gateway Investment Advisers first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Gateway Investment Advisers's Regeneron Pharmaceuticals position peaked at $18.4M in Q3 2014.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.